Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Austria Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20201
20212
20222
20233
20249
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AstraZeneca3
Bristol-Myers Squibb3
AbbVie2
ETOP IBCSG Partners Foundation2
Eli Lilly and Company2
Mirati Therapeutics Inc.2
Amgen1
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung35
Lung Neoplasms9
Neoplasms5
Carcinoma2
Lung Diseases2
Neoplasm Metastasis2
Small Cell Lung Carcinoma2
Brain Neoplasms1
Bronchial Neoplasms1
Carcinoma, Bronchogenic1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.